Displaying drugs 1451 - 1475 of 2341 in total
Acorus calamus root
Acorus calamus root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Products: … derma MOBALNA EP 90 Hair Again Toner …
Tyrphostin AG 555
Experimental
Ferritarg P
Investigational
Sucralose
Sucralose is an artificial sweetener used as a sugar substitute.
Experimental
Matched Products: … DE-LİGHT 11 MG GRANÜL İÇEREN SAŞE, 90 ADET …
Hymenialdisine
Experimental
Matched Iupac: … 5-[(3aR,4S)-2-bromo-8-oxo-3aH,4H,5H,6H,7H,8H-pyrrolo[2,3-c]azepin-4-yl]-2-amino-4H-imidazol-4-one …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
Matched Categories: … Interleukin-8, antagonists & inhibitors …
OT-551
OT-551 is a novel small molecule that is topically dosed in an eye drop and has the unique ability to penetrate cell membranes and reach both the front and the back of the eye. It is intended to treat Age-related macular Degeneration (AMD), and preclinical research results indicate additional uses...
Investigational
S-55746
Investigational
AMG-553
AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector.
Investigational
Candesartan
Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is available as a prodrug in the form of candesartan cilexetil.
Experimental
Matched Mixtures name: … โบล์เพรส 8 มิลลิกรัม พลัส ... โบล์เพรส 8 มิลลิกรัม พลัส …
Matched Products: … CANDEFAR 8 ... CANDESARTAN HENNIG 8 MG ... CANDESARTAN AL 8 MG TABL …
Matched Products: … CANDEFAR 8 ... CANDESARTAN HENNIG 8 MG ... CANDESARTAN AL 8 MG TABL …
KRN-5500
KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).
Investigational
GW-559090
Investigational
AMG-900
Investigational
HER-902
Investigational
TAK-901
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
Investigational
SR-9009
SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues .
Experimental
SR-9011
SR-9011 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues .
Experimental
IDD552
Experimental
WIN 55212-2
WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical structure. It is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of...
Experimental
T-900607
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Matched Salts cas: … 261944-77-8 …
ASN90
Investigational
SRP-9005
SRP-9005 is a rAAVrh74 vector containing a codon-optimized human SGCG transgene. Developed by the Kurt+Peter Foundation and Sarepta Therapeutics, it is being investigated for the treatment of Limb-girdle muscular dystrophy (LGMD) type 2C/R5.
Investigational
IR-901
Investigational
Recombinant neuroglobin
Investigational
Displaying drugs 1451 - 1475 of 2341 in total